Dr. Sara Mostafavi named to inaugural cohort of Canada-CIFAR AI Chairs

News

Posted on

Dr. Sara Mostafavi, a BC Children’s Hospital investigator, was named to the inaugural cohort of Canada-CIFAR AI Chairs for her work in artificial intelligence (AI) research.

The 29 chairs will receive approximately $30 million in funding as part of the $125 million Pan-Canadian AI Strategy to help maintain Canada’s leadership in artificial intelligence research.

“I am excited to be named a CIFAR AI Chair. This program is a great opportunity to build new collaborations, and connect with the growing and strong community of AI and Machine Learning researchers in Canada. I am especially looking forward to contributing to the development of new AI and ML techniques for precision medicine,” Dr. Mostafavi said.

BCCHR Communications
More by this Author

Research News

Every day, BCCHR researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

  • children playing outdoors
    News

    Billions of doses later, global review confirms mRNA vaccines are safe

    A sweeping global review research has found that mRNA vaccines are safe and highly effective at preventing infectious diseases, such as COVID-19. These vaccines also have potential applications for a range of other diseases, including influenza, respiratory syncytial virus (RSV), cancer, and autoimmune disorders.

    Read more
  • Young child holding their head
    News

    Emerging treatment options offer hope to children affected by migraine

    Headache disorders, such as migraine, can drastically disrupt daily life. Still, they are underestimated, underrecognized, and undertreated. Migraine is among the top three causes of disability in individuals aged 10 to 24, with 10 per cent of children experiencing it before reaching puberty. Migraine is associated with school absenteeism, disengagement from extracurricular activities, and decreased…

    Read more
  • News

    Gut fungi may hold the key to treating asthma, allergies worldwide

    Two new studies jointly published in Nature: The Clinical Microbiome reveal that certain species of fungi in the gut play a key role in the development of immune dysregulation and some pediatric allergic diseases — and may be promising targets for new therapies.

    Read more

Donate to Research

With your support, we believe there’s nothing we can’t do. Funding helps bring hope out of the laboratory and into the clinic — to save and improve children’s lives.

donate now